Analysis of the key themes driving M&A activity reveals that virtual care accounted for 3 pharmaceutical deals announced in Q3 2023, worth a total value of $4.2m. The $4.2m acquisition of Undisclosed – Four Alberta-Based Diagnostic Imaging Clinics – Canada from Undisclosed by LevelJump Healthcare was the industry’s largest disclosed deal. GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for Q3 2023 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. Buy the report here.
In value terms, virtual care-related deal activity decreased by 99% in Q3 2023 compared with the previous quarter’s total of $367m. Related deal volume decreased by 25% in Q3 2023 versus the previous quarter and was 200% higher than in Q3 2022.
The top-ranked financial advisors supporting these M&A deals in Q3 2023 were Deutsche Bank; Evercore; Jefferies Financial Group with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these M&A deals in Q3 2023 were DLA Piper; Dua & Associates; Greenberg Traurig with 1, 1, 1 deals respectively.
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in Q3 2023 – Thematic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.